Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Saigal

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Brachytherapy|October 11, 2016
Time-driven activity-based costing of low-dose-rate and high-dose-rate brachytherapy for low-risk prostate cancerAnnette M Ilg, Aaron A Laviana, Mitchell Kamrava, et al.
Urology|February 14, 2024
The Future State of Race/Ethnicity in Urology: Urology Workforce Projection From 2021-2061Ashley Appleton, Kristian Black, Nicholas C Sellke, et al.
Urology|October 22, 2022
Someone Like Me: An Examination of the Importance of Race-Concordant Mentorship in UrologyNatalia Garcia Penaloza, Kassandra E Zaila Ardines, Serena Does, et al.
Urology|June 19, 2022
Racial and Ethnic Differences in Medical Student Timing and Perceived Quality of Exposure to UrologyEfe C Ghanney Simons, Kassandra E Zaila Ardines, Natalia Garcia Penaloza, et al.
Urology Practice|June 14, 2023
Quality Improvement Summit 2016: Shared Decision Making and Prostate Cancer ScreeningDanil V Makarov, Margaret Holmes-Rovner, David R Rovner, et al.
International Journal of Radiation Oncology, Biology, Physics|August 25, 2022
Quality-of-Life Outcomes and Toxicity Profile Among Patients With Localized Prostate Cancer After Radical Prostatectomy Treated With Stereotactic Body Radiation: The SCIMITAR Multicenter Phase 2 TrialTing Martin Ma, Leslie K Ballas, Holly Wilhalme, et al.
JAMA Oncology|May 15, 2025
Patient-Reported Outcomes With Stereotactic Intensity Modulated Radiotherapy After Radical Prostatectomy: A Nonrandomized Clinical TrialJohn Nikitas, Leslie K Ballas, Tahmineh Romero, et al.
European Urology|October 1, 2025
Stereotactic Intensity-modulated Radiotherapy After Radical Prostatectomy (SCIMITAR): 4-Year Outcomes of a Phase 2 Clinical TrialAmar U Kishan, Jesus E Juarez Casillas, Paul Sargos, et al.
JAMA Network Open|December 29, 2021
Comparison of Response to Definitive Radiotherapy for Localized Prostate Cancer in Black and White Men: A Meta-analysisTing Martin Ma, Tahmineh Romero, Nicholas G Nickols, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Brachytherapy|October 11, 2016
Time-driven activity-based costing of low-dose-rate and high-dose-rate brachytherapy for low-risk prostate cancerAnnette M Ilg, Aaron A Laviana, Mitchell Kamrava, et al.
Urology|February 14, 2024
The Future State of Race/Ethnicity in Urology: Urology Workforce Projection From 2021-2061Ashley Appleton, Kristian Black, Nicholas C Sellke, et al.
Urology|October 22, 2022
Someone Like Me: An Examination of the Importance of Race-Concordant Mentorship in UrologyNatalia Garcia Penaloza, Kassandra E Zaila Ardines, Serena Does, et al.
Urology|June 19, 2022
Racial and Ethnic Differences in Medical Student Timing and Perceived Quality of Exposure to UrologyEfe C Ghanney Simons, Kassandra E Zaila Ardines, Natalia Garcia Penaloza, et al.
Urology Practice|June 14, 2023
Quality Improvement Summit 2016: Shared Decision Making and Prostate Cancer ScreeningDanil V Makarov, Margaret Holmes-Rovner, David R Rovner, et al.
International Journal of Radiation Oncology, Biology, Physics|August 25, 2022
Quality-of-Life Outcomes and Toxicity Profile Among Patients With Localized Prostate Cancer After Radical Prostatectomy Treated With Stereotactic Body Radiation: The SCIMITAR Multicenter Phase 2 TrialTing Martin Ma, Leslie K Ballas, Holly Wilhalme, et al.
JAMA Oncology|May 15, 2025
Patient-Reported Outcomes With Stereotactic Intensity Modulated Radiotherapy After Radical Prostatectomy: A Nonrandomized Clinical TrialJohn Nikitas, Leslie K Ballas, Tahmineh Romero, et al.
European Urology|October 1, 2025
Stereotactic Intensity-modulated Radiotherapy After Radical Prostatectomy (SCIMITAR): 4-Year Outcomes of a Phase 2 Clinical TrialAmar U Kishan, Jesus E Juarez Casillas, Paul Sargos, et al.
JAMA Network Open|December 29, 2021
Comparison of Response to Definitive Radiotherapy for Localized Prostate Cancer in Black and White Men: A Meta-analysisTing Martin Ma, Tahmineh Romero, Nicholas G Nickols, et al.
Pageof 4